DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 23, 2007; DOI: 10.1124/dmd.107.014787


0090-9556/07/3510-1910-1915$20.00
DMD 35:1910-1915, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
dmd.107.014787v1
35/10/1910    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuester, R. K.
Right arrow Articles by Sipes, I. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuester, R. K.
Right arrow Articles by Sipes, I. G.

Prediction of Metabolic Clearance of Bisphenol A (4,4 '-Dihydroxy-2,2-diphenylpropane) using Cryopreserved Human HepatocytesFormula

R. K. Kuester, and I. G. Sipes

Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona

This study investigated the kinetics of glucuronidation of bisphenol A (BPA; 4,4'-dihydroxy-2,2-diphenylpropane) in cryopreserved human hepatocytes (HCs). Incubation conditions were developed using Sprague-Dawley rat HCs. For determination of the kinetic constants of BPA glucuronidation rates with human HCs, viable HCs (0.125 x 106) were incubated with [14C]BPA (1.3-52 µM) for 10 min. The glucuronidation reaction demonstrated Michaelis-Menten kinetics and yielded a mean Km for males and females of 9 ± 3 and 8 ± 2 µM, respectively. The Vmax values of these reactions were 438 ± 129 pmol/min/106 for male HCs and 480 ± 208 pmol/min/106 for female HCs. The scaled intrinsic clearance (CLint) for male human HCs was 149 ± 67 ml/min/kg (range 53-246) and for female HCs was 165 ± 89 ml/min/kg (range 73-336). Overall, there are no apparent gender differences in the glucuronidation of BPA. These CLint values were then extrapolated to estimate total hepatic metabolic clearance (CLmet) using a nonrestrictive well stirred model. The estimated CLmet value for both male and female HCs was 6 ml/min/kg, which represents 30% of hepatic blood flow. Thus, in vivo clearance seems to depend highly on plasma protein binding. These in vitro results correlate well with in vivo studies in humans, which report extensive glucuronidation of BPA.


Address correspondence to: Dr. I. Glenn Sipes, Department of Pharmacology, College of Medicine, The University of Arizona, P.O. Box 245050, Tucson, AZ 85724-5050. E-mail: sipes{at}email.arizona.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.